United States· US:68071-2491_239ad172-5ff6-b95f-e063-6394a90aa1d9
NYSTATIN AND TRIAMCINOLONE ACETONIDE
A medicinal product containing nystatin; triamcinolone acetonide, registered in United States by NuCare Pharmaceuticals,Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NYSTATIN; TRIAMCINOLONE ACETONIDE
- Manufacturer
- NuCare Pharmaceuticals,Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1168071-2491-3
- ndc1168071249131 TUBE in 1 CARTON (68071-2491-3) / 30 g in 1 TUBE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7c4ddbe-57b9-4fa3-8c47-e951ba1b2d25 GET /v1/drugs/e7c4ddbe-57b9-4fa3-8c47-e951ba1b2d25?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "100000; 1",
"substance": "NYSTATIN; TRIAMCINOLONE ACETONIDE",
"productndc": "68071-2491",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "[USP'U]/g; mg/g",
"application_number": "ANDA208479",
"marketing_category": "ANDA"
}See everything about nystatin; triamcinolone acetonide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.